Home
Prelude Therapeutics

Prelude Therapeutics Market Share Analysis for June 2026

Prelude was founded in 2016 with the vision of bringing together the energy and collaborative culture of a start-up environment with seasoned experience in developing cancer medicines. Prelude Therapeutics is a leading precision oncology company developing innovative medicines in areas of high unmet need for cancer patients. Our pipeline features highly selective KAT6A degraders and […]

Health > Biotechnology and Pharmaceuticals

Domainpreludetx.com

Year Founded2016

Employees51 - 200

Annual Revenue$25M - $50M

Prelude Therapeutics

Prelude Therapeutics (including company regionals)

preludetx.com

See more website traffic and engagement information

Prelude Therapeutics Revenue up to June 2026 is 25M - 50M

revenue generated by Prelude Therapeutics top domains

Prelude Therapeutics top domains revenue over 3 years

Revenue for Prelude Therapeutics top domains

preludetx.com25M - 50M

See more with Sales Intelligence

Total visits to Prelude Therapeutics's top domains

Understand Prelude Therapeutics market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

preludetx.com9.1K

See more with Sales Intelligence

Avg. visit duration in Prelude Therapeutics's top domains

Analyze Prelude Therapeutics engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

preludetx.com00:00:04

See more with Sales Intelligence

Avg. pageviews on Prelude Therapeutics's top domains

See how Prelude Therapeutics keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

preludetx.com1.70

See more with Sales Intelligence

Prelude Therapeutics top competitors by domain

Looks like there’s not enough data here

No Data to Display

Top technologies used by Prelude Therapeutics

These are the website technologies, by industry, used by Prelude Therapeutics top domains

Widget (4)

Twemoji

Advertising (3)

Google Adsense

Conversion & Analytics (2)

Google Analytics

Mobile (2)

Meta Viewport

More Technologies

6

See all

News & Signals from Prelude Therapeutics

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsPrelude Therapeutics Incorporated attended event Annual Meeting on Jan 1st '26.Prelude Therapeutics presents preclinical data from development candidate, PRT13722, a first-in-class, orally bioavailable, potent and highly selective KAT6A degrader at american association for cancer research (AACR) Annual Meeting 2026.

NewsPrelude Therapeutics Incorporated attends event 2025 AACR Annual Meeting.Prelude announces Presentations at 2025 AACR Annual Meeting.

NewsPrelude Therapeutics Incorporated attended event Barclays 27th Annual Global Healthcare Conference on Mar 5th '25.WILMINGTON, Del., March 05, 2025 (GLOBE NEWSWIRE) - Prelude Therapeutics Incorporated (Prelude) (Nasdaq: PRLD), a clinical-stage precision oncology company, announced today that the Company will participate in the Barclays 27th Annual Global Healthcare Conference, taking place in Miami, FL on March 11, 2025.